Little is known about the honey bees (Apis mellifera) found across the Middle East and North Africa (MENA). This is true, despite the economic value of beekeeping in the region, and the particularly high value of sidr honey, which comes from the Arabian Peninsula (Alqarni et al. 2011). Regionally, beekeepers report abnormally high rates of honeybee mortality and disappearance of colonies here (Haddad 2011), yet scant data addresses bee pathogens and disease. Nearly all bee disease research in MENA involves the subspecies Apis mellifera intermissa (Adjlane et al. 2012a, b; Belaid and Et Doumandji 2010; El-Niweiri and El-Sarrag 2006; El-Niweiri et al. 2008; Haddad 2014; Haddad et al. 2015; Ellis and Munn 2005). However, Apis mellifera jemenitica is another important subspecies, with a native range that extends from Senegal to the Arabian Peninsula. A.m. jemenitica is valued for beekeeping (Ruttner 1975; Al-Ghamdi et al. 2013) yet no data exists on pathogen prevalence for this subspecies. Nor is there molecular disease data for bees in Yemen, where the major agricultural reference (Agricultural Statistical Book 2012) lists honeybee “pests and diseases” merely as wax moths, hornets, bee wolves, bee-eaters, and varroa mites.

This work evaluates pathogen prevalence in A. m. jemenitica in Yemen. Honey bees were collected at 16 sites (~50 workers/site) in nine beekeeping regions of Yemen (Figure 1). Individual bees were randomly collected from inside colonies exhibiting signs of disease, including deformed wings, hairlessness, crawling around the hive entrance, and reduced colony size. Collected bees were immediately preserved in ethanol (Evans et al. 2013), shipped to Jordan, removed from ethanol, then stored at −80°C.

Figure 1.
figure 1

A map with the location of the 16 geographic sites sampled across Yemen for the presence of viral disease and Nosema in honeybee colonies that appeared sick. Site 1 and 2 are located in Shabwa, 3 and 4 in Addali, 5 and 6 in Sana’a, 7 and 8 in Lahj, 9 and 10 in Marib, 11 and 12 in Hadramaut, 13 in Amran, 14 and 15 in Ibian, and 16 in Al jawf.

1 RNA extraction and RT-PCR

For RT-PCR analysis, five to seven bees were randomly selected from each collection, then homogenized with 1 mL Trizol (Biobasic) using new, alcohol-disinfected, autoclave-sterilized mortar and pestles. Homogenate was transferred to 1.5 mL microfuge tubes. The protein fraction was separated out in the organic fraction with chloroform, and the RNA was precipitated from the aqueous phase with 1 mL of isopropanol and centrifugation at 14,000rpm. The resultant nucleic acid pellets were washed two times with 70% ethanol and then resuspended in nuclease-free water. Each RNA sample of homogenized material per colony was analyzed for the presence of bee viral sequences using the Access RT-PCR system (Promega, USA) according to the company protocol. Amplification occurred in a 25-μL reaction mixture containing 1X reaction buffer, 0.2mM dNTP, 1 μM each of the forward and reverse primers for each viral sequence, 2 mM MgSO4, 0.1 U of avian myeloblastosis virus reverse transcriptase, 0.1 U of’ Tfl DNA polymerase, and 250 to 500 ng of total RNA. Reverse transcription occurred at 48 °C for 48 min and was followed by 40 cycles of 95 °C for 30 s, 55 °C for 1 min, 68 °C for 2 min, and a final extension at 68 °C for 7 min. Positive and negative controls were included in each RT-PCR experimental run. Ten microliters of amplified product was electrophoresed in a 2% agarose gel and stained with ethidium bromide. Bands were photographed under UV light. A 100-bp reference ladder (Promega) was used to estimate fragment sizes.

Bees were assayed via reverse transcription polymerase chain reaction for deformed wing virus (DWV), Israeli acute paralysis virus (IAPV), chronic bee paralysis virus (CBPV), slow bee paralysis virus (SBPV), Kashmir bee virus (KBV), acute bee paralysis virus (ABPV), Sacbrood virus (SBV), Varroa destructor virus-1 (VDV-1), and via polymerase chain reaction for two microsporidian species, Nosema cerana and N. apis using previously published primers.

2 DNA extraction and PCR amplification

For microsporidian PCR work, DNA was extracted from ~45 bees per collection with Nucleospin extraction kits (Macherey-Nagel). DNA was suspended in 100 μL of 5 mM Tris and stored at −80°C. PCR for rRNA genes of N. ceranae and N. apis was conducted using previously published primers. 50–80 ng/uL DNA was used per reaction. PCR protocol was denaturation at 95 °C for 2 min, 35 cycles of 95°C for 20 s, 56 °C for 20 s, and 72 °C for 30 s, with a final extension at 72 °C for 5 min. Products were analyzed on 1% agarose gels with reference ladders, stained with ethidium bromide and visualized under UV light.

3 Results

We found honeybee pathogens and disease to be widespread in Yemen. High levels of varroa mites were found at all hives assayed. Most sites (n = 10/16) tested positive for at least one virus (Table I), with infection broadly distributed geographically (Figure 1).

Table I Presence (+) and absence (−) results of RT-PCR assays for eight honey bee viruses and PCR assays for two Nosema species in 16 total samples from nine beekeeping regions in Yemen. All colonies presented with varroa mites and exhibited signs of disease

The south central region of Yemen, Shabwa (sites 1 and 2, Figure 1) tested positive for three viruses (DWV, ABPV, and IAPV) plus N. ceranae. However, northeast of Shabwa, ~200+ km, in Hadramaut, no viruses or Nosema sp. were detected. Yet, southwest of Shabwah, ~200 km, Ibian (sites 14, 15) tested positive for two different viruses (VDV, KBV) plus N. apis. West of Ibian ~100km, in Addali (sites 3, 4) no pathogens were detected. Southwest of Addali, ~100 km away in Lahj (sites 7, 8), only N. apis was detected.

Moving to the northwestern section of Yemen, due north of Lahj ~200km, Sana’a (sites 5, 6) tested positive for two viruses (DWV, KBV) and both Nosema sp. To the east of Sana’a ~150 km, in Marib (sites 9, 10), one virus (DWV) and both Nosema sp. were present. Further north of Marib, another ~100 km, in Al jawf (site 16), one virus (DWV) and N. apis were detected. West and slightly south of Al jawf ~100km, in Amran (site 13), one virus (KBV) and N. apis were detected.

In sum, DWV was present at 6/16 sites, KBV at 5/16 sites, ABPV at 2/15 sites, and IAPV and VDV at 1/16 sites each. No sites demonstrated evidence of infection with CBPV, SBPV or SBV. Nosema was also widespread at 10/16 sites. N. apis was detected at 7/16 sites and was more common than N. cerana, which was detected at 3/16 sites. Two sites tested positive for both Nosema species. There was one case of N. cerana in the absence of N. apis, and five cases of N. apis found in the absence of N. cerana. On average, colonies testing positive for infection had 2.27 pathogenic species present. Most sites differed from one another in total pathogen complement, however N. apis plus either DWV or KBV were the parasites found together most often.

This work shows that A. m. jemenitica demonstrates various pathogenic infections throughout much of Yemen, but not in Hadramaut, an important region for the production of sidr honey. Our work complements the only other study (Allen and Ball 1996) that, to our knowledge, assesses viruses in MENA. That work occurred in a different part of MENA (Saudi Arabia), and involved different (serological) methods. In Saudi Arabia, A. m. jementica shows signs of disease, but until now mites (Varroa jacobsoni) and bee lice (Braula coeca) were considered the most abundant parasites in apiaries (Al-Ghamdi et al. 2013). Recently, Apis mellifera carnica was imported into Saudi Arabia, largely from Egypt (Ali 2011) which could expose A. m. jemenitica to novel parasites. Other subspecies have also shown molecular evidence of infection in this major geographic region, including in Jordan (Haddad et al. 2008), United Arab Emirates (Berenyi et al. 2007), and Algeria (Loucif-Ayad et al. 2013). Further work is clearly warranted on pathogenic disease in honey bee subspecies across MENA, as well as on the impact of migration of subspecies upon one another, and the likelihood for transmission of disease when this occurs.